Table 1.
Disease-specific survival analysis in 75 breast cancer patients.
| Univariate analysis (N = 73/75 cases) |
Multivariate analysis |
|||
|---|---|---|---|---|
| Parameters | HR (CI 95%) | p | HR (CI 95%) | p |
|
Age (years) ≤55 >55 |
1.0 5.658 (0.654–48.949) |
0.1154 | ||
|
Clinical stage I, IIA, IIB IIIA, IIIB |
1.0 23.301 (2.589–209.744) |
0.0050 | ||
|
Tumour size (mm) ≤20 >20 |
1.0 nd |
0.9950 | ||
|
Lymph nodes involvement ≤4 >4 |
1.0 14.271 (1.632–124.788) |
0.0163 | ||
|
Metastasis Presence Absence |
1.0 18.792 (3.093−114.186) |
0.0014 |
1.0 18.792 (3.093−114.186) |
0.0014 |
|
Histological grade I, II III |
1.0 1.230 (0.248–6.111) |
0.8001 | ||
|
ER Positive Negative |
1.0 4.288 (0.768–23.939) |
0.0971 | ||
|
PgR Positive Negative |
1.0 nd |
0.9959 | ||
|
Her-2 Negative Positive |
1.0 1.506 (0.167–13.590) |
0.7151 | ||
|
p53 Negative Positive |
1.0 0.568 (0.062–5.213) |
0.6169 | ||
|
Proliferative index (Ki-67) Low (≤25%) High (>25%) |
1.0 0.640 (0.117–3.508) |
0.6069 | ||
HR: Hazard Ratio; CI: Confidence Interval; N: Number of cases; nd: not determined; in bold: p-value <0,05.